- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06593470
Prevenzione per uso di sostanze basate sulla consapevolezza (mentali) (MINDS-UP)
Prevenzione dell'uso di sostanze basate sulla consapevolezza (mentalità-up): uno studio controllato randomizzato
The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The aims of the study are:
Aim 1: Determine feasibility and acceptability of MINDS-UP as a preventive intervention via a) retention, b) attendance, c) teacher-rated participation, d) student-rated participation, e) homework completion, and f) acceptability.
Aim 2: Evaluate neuropsychological mechanisms (target engagement) of MINDS-UP.
Aim 3 (Exploratory): Assess preliminary efficacy of MINDS-UP on substance use initiation (SUI).
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: David C Saunders, MD, PhD
- Numero di telefono: 914-409-6807
- Email: david.saunders@nyspi.columbia.edu
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Youth is ages 10-14 years on the day of screening [i.e., does not turn 15 before or on the day of screening]
- Youth has access to a smartphone, tablet, or computer with Wi-Fi
- Youth and parent are English-speaking
Exclusion Criteria:
1. The youth has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Sport: Prevention Plus Wellness (PPW)
Sport: Prevention Plus Wellness (PPW) is a brief, evidence-based substance use prevention program for youth. PPW consists of a single self-administered 45-minute session that is interactive and intended for use by youth in the home setting. It involves screening youth to increase awareness of their current health behaviors; motivational enhancement for change; and establishing a behavior goal plan. |
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45 minute self-administered online course.
Altri nomi:
|
|
Sperimentale: PPW + MINDS-UP
MINDS-UP consists of 4 x 60-minute sessions, once weekly over 4 weeks. MINDS-UP will be delivered to participants remotely, in a 1:1 setting, taught by the meditation teachers that will be hired and trained by Dr. Saunders. Additionally, participants will be provided audio files of 5-10-minute guided meditation practices, led by Dr. Saunders, as homework. Participants randomized to MINDS-UP will also complete PPW, a 45 minute, self-administered course. |
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45 minute self-administered online course.
Altri nomi:
MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Retention
Lasso di tempo: Completion of Study (up to 36 months)
|
Percent of participants who completed all study procedures among those who were randomized |
Completion of Study (up to 36 months)
|
|
Attendance
Lasso di tempo: Completion of Study (up to 36 months)
|
Percent of scheduled sessions that were completed by the participant. |
Completion of Study (up to 36 months)
|
|
Teacher Rated Participation
Lasso di tempo: Completion of Study (up to 36 months)
|
Research Assessment Package for Schools - Teacher Rated |
Completion of Study (up to 36 months)
|
|
Student-Rated Participation
Lasso di tempo: Completion of Study (up to 36 months)
|
Research Assessment Package for Schools - Student Engagement |
Completion of Study (up to 36 months)
|
|
Homework Completion
Lasso di tempo: Completion of Study (up to 36 months)
|
Percentage of assigned homeworks that were completed by the participant. |
Completion of Study (up to 36 months)
|
|
Acceptability
Lasso di tempo: Completion of Study (up to 36 months)
|
Acceptability of Intervention Measure |
Completion of Study (up to 36 months)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Total Problems (parent-report)
Lasso di tempo: 4-8 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 98 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems |
4-8 weeks, 6 months, and 12 months
|
|
ADHD Symptoms
Lasso di tempo: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the ADHD Rating Scale, an 18-item parent-report assessment that measures adolescent behaviors related to ADHD (inattentiveness, hyperactivity). |
4-6 weeks, 6 months, and 12 months
|
|
Suicidal Thoughts/Behaviors
Lasso di tempo: 4-6 weeks, 6 months, 12 months
|
The C-SSRS is a gold-standard assessment tool for suicide risk. This tool will be administered at every visit. |
4-6 weeks, 6 months, 12 months
|
|
Alcohol sipping
Lasso di tempo: 4-6 weeks, 6 months, and 12 months
|
Low-level and early alcohol use as characterized by the iSay Sipping Inventory. This survey characterizes low level and first/early alcohol use, including age at first sip, whether that drink was completed, and behaviors after the first sip. |
4-6 weeks, 6 months, and 12 months
|
|
Tobacco Use
Lasso di tempo: 4-6 weeks, 6 months, and 12 months
|
Tobacco use as measured by Tobacco Low Level Use Measure. This is a short tool that measures number of times used, type of tobacco/nicotine used, duration of use, and frequency of use. |
4-6 weeks, 6 months, and 12 months
|
|
Cannabis Use
Lasso di tempo: 4-6 weeks, 6 months, and 12 months
|
Cannabis use as measured by the Marijuana Low-Level Use Measure, a short tool that measures early/first use of cannabis. |
4-6 weeks, 6 months, and 12 months
|
|
Total Problems (adolescent report)
Lasso di tempo: 4-6 weeks, 6 months, 12 months
|
The Youth Self Report (YSR) is the self-report adolescent version of the Child Behavior Checklist, and is used to assess emotional and behavioral problems in children and adolescents. |
4-6 weeks, 6 months, 12 months
|
|
Mindfulness
Lasso di tempo: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the Child and Adolescent Mindfulness Measure (CAMM); the CAMM is a 10-item measure of self-reported mindfulness; scores range from 0 to 40, with higher scores indicating higher mindfulness |
4-6 weeks, 6 months, and 12 months
|
|
Anxiety and Depression
Lasso di tempo: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6 and 12 month-follow-up) difference in score on the Revised Childhood Anxiety and Depression scale, a 47-item self-report scale that assesses childhood/adolescent anxiety and depression symptoms across six sub-domains. |
4-6 weeks, 6 months, and 12 months
|
|
Perceived Tolerance of Use
Lasso di tempo: baseline
|
The Perceived Tolerance of Use is a tool that assesses peer tolerance of use of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is a tool that is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use. |
baseline
|
|
Perceived Harm of Substance Use
Lasso di tempo: baseline
|
The Perceived Harm of Substance Use tool assesses perceived harm of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use. |
baseline
|
|
Beliefs About Alcohol Effects
Lasso di tempo: baseline
|
The Brief Comprehensive Effects of Alcohol Questionnaire is a 15-item self-report version of the Comprehensive Effects of Alcohol Questionnaire that is used by the ABCD study to assess an adolescent's expectations of using alcohol. |
baseline
|
|
Beliefs About Smoking Effects
Lasso di tempo: baseline
|
The Adolescent Smoking Consequences Questionnaire (ASCQ) is a 30-item self-report instrument used to assess outcome expectancies of cigarette smoking among adolescents. |
baseline
|
|
Beliefs About Cannabis Effects
Lasso di tempo: baseline
|
Brief -Marijuana Effect Expectancies Questionnaire (MEEQ-B) is a 6-item self-report assessment of an adolescent's expected effect of marijuana. |
baseline
|
|
Risk and Protective Factors
Lasso di tempo: Baseline
|
The Community Risk and Protective Factors Survey is a 24-item parent-report tool to assess adolescent's experience of exposure to substance use risk and protective factors in the community. |
Baseline
|
Collaboratori e investigatori
Collaboratori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- #Pro00076319
- K12DA000357 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .